Orphan designation: talquetamab Treatment of multiple myeloma, 20/08/2021 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 10 November 2026 - 10:22

Orphan designation: talquetamab Treatment of multiple myeloma, 20/08/2021 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2486

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters